Evidence map›Paper›PMID 32430336›Full record

SynthesisProceedings of the National Academy of Sciences of the United States of America2020

NIH funding and the pursuit of edge science.

Mikko Packalen, Jay Bhattacharya

Abstract readMeta-Analysis
In one paragraph

Synthesis in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. NIH funding and the pursuit of edge science.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. How the National Library of Medicine should evolve in an era of artificial intelligence.Journal of the American Medical Informatics Association : JAMIA · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Promotional language and the adoption of innovative ideas in science.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mikko PackalenDepartment of Economics, University of Waterloo, Waterloo, ON, Canada N2L 3G1.
Jay BhattacharyaCenter for Health Policy/Primary Care and Outcomes Research, Department of Medicine, Stanford University, Stanford, CA 94305 jay@stanford.edu.ORCID 0000-0003-3867-3174

Funding

LIFE CYCLE EVENTS, PRODUCTIVITY, AND SCIENTIFIC IMPACTP01AG039347 · NIA · NATIONAL BUREAU OF ECONOMIC RESEARCH · PI WEINBERG, BRUCE A · 2013 to 2018
$5.4M
NIA NIH HHS P01 AG039347
6 · The paper itself

Abstract

The National Institutes of Health (NIH) plays a critical role in funding scientific endeavors in biomedicine. Funding innovative science is an essential element of the NIH's mission, but many have questioned the NIH's ability to fulfill this aim. Based on an analysis of a comprehensive corpus of published biomedical research articles, we measure whether the NIH succeeds in funding work with novel ideas, which we term edge science. We find that edge science is more often NIH funded than less novel science, but with a delay. Papers that build on very recent ideas are NIH funded less often than are papers that build on ideas that have had a chance to mature for at least 7 y. We have three further findings. First, the tendency to fund edge science is mostly limited to basic science. Papers that build on novel clinical ideas are not more often NIH funded than are papers that build on well-established clinical knowledge. Second, novel papers tend to be NIH funded more often because there are more NIH-funded papers in innovative areas of investigation, rather than because the NIH funds innovative papers within research areas. Third, the NIH's tendency to have funded papers that build on the most recent advances has declined over time. In this regard, NIH funding has become more conservative despite initiatives to increase funding for innovative projects. Given our focus on published papers, the results reflect both the funding preferences of the NIH and the composition of the applications it receives.

Indexed as

National Institutes of Health (U.S.)Biomedical ResearchFinancing, OrganizedHumansScienceUnited Statesbiomedicinefundingideasnoveltyscience

Identifiers

PMID32430336
PMCPMC7275727

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.